NHS Logo
  • Home
  • Impact
  • About Us
    • Contact Us
    • NIHR Imperial BRC Team
    • Equality, Diversity and Inclusion (EDI) Strategy
    • NIHR Infrastructures
    • Acknowledgement
    • Research Guidance & Useful Links
    • NIHR Imperial BRC Branding Guidance
  • Research
    • Biomedical Engineering
    • Brain Sciences
    • Cardiovascular
    • Digestive Diseases
    • Digital Health
    • Immunology
    • Infection & Antimicrobial Resistance
    • Metabolic & Endocrinology
    • Molecular Phenotyping
    • Multiple Long-term Conditions (MLTC)
    • Pregnancy & Prematurity
    • Respiratory
    • Social, Genetic & Environmental Determinants of Health (SGE)
    • Surgery & Cancer
  • Facilities/Services
    • Clinical Imaging Facility
    • Clinical Phenotyping Centre
    • Flow Cytometry
    • Genomics Facility
    • Imperial College Healthcare Tissue Bank
    • iCARE
    • Imperial Clinical Trials Unit
    • Imperial Health Knowledge Bank (IHKB)
    • Organoid Facility
    • Patient Experience Research Centre (PERC)
    • The Leonard and Dora Colebrook Laboratory
  • Patient/Public
    • Research We Are Supporting
    • How You Can Get Involved
    • Information for Researchers
    • Public Involvement, Engagement and Participation in Research Summary Strategy
  • Industry/Partners
    • NIHR Imperial BRC Primary Care Research Unit (PCRU)
    • Collaborations
    • Contract
    • Commercialisation
  • Training
    • Non-Medical Opportunities
    • Chain Florey Clinician Scientist Programme
    • Clinical Academic Training Office
    • Other Training Schemes
  • News & Events
    • Upcoming Events
    • Newsletter

Prevention Stories

First in HumanPrevention First-in-Human Trials Launch for Vaccines Against Ebola, Marburg and Lassa

First in HumanPrevention First-in-Human Trials Launch for Vaccines Against Ebola, Marburg and Lassa

Published on 23rd January 2026
Prevention AI-powered tool may accelerate the discovery of heart disease treatments

Prevention AI-powered tool may accelerate the discovery of heart disease treatments

Published on 6th January 2026
Prevention ACE2 Protein May Help Prevent High Blood Pressure and Diabetes

Prevention ACE2 Protein May Help Prevent High Blood Pressure and Diabetes

Published on 22nd December 2025
PreventionTreatment Liraglutide, a Weight-loss Medication, Found to Slow Alzheimer’s Progression

PreventionTreatment Liraglutide, a Weight-loss Medication, Found to Slow Alzheimer’s Progression

Published on 11th December 2025
Prevention Ambitious Prostate Cancer Screening Study, TRANSFORM, Commences with First Participants

Prevention Ambitious Prostate Cancer Screening Study, TRANSFORM, Commences with First Participants

Published on 21st November 2025
Information for Patients and the Public
  • Research We Are Supporting
  • How You Can Get Involved
  • Public Involvement, Engagement and Participation in Research Summary Strategy
Latest News
  • Funding Call Celebrating 20 Years of NIHR: Research Leaders Prizes
  • Funding Call ZeDTech Funding for Feasibility Research on Dementia Support Technologies
  • First in HumanPrevention First-in-Human Trials Launch for Vaccines Against Ebola, Marburg and Lassa
NIHR Imperial Biomedical Research Centre

The National Institute for Health and Care Research (NIHR) Imperial Biomedical Research Centre (BRC) is part of the NIHR and hosted by Imperial College Healthcare NHS Trust in partnership with Imperial College London


Accessibility
Privacy
Terms & Conditions

The information contained in this website is for general use only. We endeavour to keep the information on the site up to date and correct, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose.

© 2026 - NIHR Imperial Biomedical Research Centre